Sharon E Maynard
Overview
Explore the profile of Sharon E Maynard including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
20
Citations
3650
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Prince L, Howle A, Mikita J, YBarbo B, Maynard S, Sussman A, et al.
Am J Kidney Dis
. 2021 Mar;
78(4):541-549.
PMID: 33741490
Rationale & Objective: Interpersonal communication skills and professionalism competencies are difficult to assess among nephrology trainees. We developed a formative "Breaking Bad News" simulation and implemented a study in which...
2.
Souders C, Maynard S, Yan J, Wang Y, Boatright N, Sedan J, et al.
Int J Mol Sci
. 2015 Jun;
16(6):12436-53.
PMID: 26042465
Angiogenic biomarkers, including soluble fms-like tyrosine kinase 1 (sFlt1), are thought to be predictors of preeclampsia onset; however, improvement is needed before a widespread diagnostic test can be utilized. Here...
3.
Moore Simas T, Crawford S, Bathgate S, Yan J, Robidoux L, Moore M, et al.
J Matern Fetal Neonatal Med
. 2013 Sep;
27(10):1038-48.
PMID: 24066977
Objective: Chronic hypertension, pregestational diabetes mellitus, history of prior preeclampsia and obese nulliparity are maternal conditions associated with increased preeclampsia risk. Whether altered maternal angiogenic factor levels allow for prediction...
4.
5.
Maynard S, Crawford S, Bathgate S, Yan J, Robidoux L, Moore M, et al.
Am J Obstet Gynecol
. 2013 Mar;
209(1):53.e1-9.
PMID: 23517919
Objective: Several conditions are associated with increased preeclampsia (PE) risk. Whether altered maternal angiogenic factor levels contribute to risk in these conditions is unknown. Our objective was to compare angiogenic...
6.
Moore A, Young H, Keller J, Ojo L, Yan J, Moore Simas T, et al.
J Matern Fetal Neonatal Med
. 2012 Aug;
25(12):2651-7.
PMID: 22861812
Objective: To determine if maternal serum angiogenic factors predict maternal and neonatal complications in women presenting to an acute care setting with suspected preeclampsia. Study Design: Maternal serum samples were...
7.
Maynard S, Karumanchi S
Semin Nephrol
. 2011 Jan;
31(1):33-46.
PMID: 21266263
Preeclampsia, a hypertensive disorder peculiar to pregnancy, is a systemic syndrome that appears to originate in the placenta and is characterized by widespread maternal endothelial dysfunction. Until recently, the molecular...
8.
Ganesan C, Maynard S
J Nephrol
. 2011 Jan;
24(5):554-63.
PMID: 21240869
Acute kidney injury (AKI) is a rare but serious complication of pregnancy. Although prerenal and ischemic causes of AKI are most common, renal insufficiency can complicate several other pregnancy-specific conditions....
9.
Maynard S, Moore Simas T, Bur L, Crawford S, Solitro M, Meyer B
Hypertens Pregnancy
. 2010 Jul;
29(3):330-41.
PMID: 20670156
Objectives: To evaluate soluble endoglin (sEng) and the soluble fms-like tyrosine kinase 1 (sFlt1) to placental growth factor (PlGF) ratio for the prediction of preeclampsia in high-risk women, and to...
10.
Nguyen M, Maynard S, Kimmel P
Clin J Am Soc Nephrol
. 2009 Mar;
4(3):528-34.
PMID: 19261813
Equations for estimating GFR, quantifying urinary protein excretion, and assessing renal sodium handling are widely used in routine nephrology and general medical and surgical practice. If these equations are applied...